GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (OTCPK:FSXMF) » Definitions » Shiller PE Ratio

Faes Farma (Faes Farma) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Faes Farma Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Faes Farma Shiller PE Ratio Historical Data

The historical data trend for Faes Farma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Shiller PE Ratio Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.01 22.54 18.71 16.33 -

Faes Farma Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.74 16.33 14.20 14.36 -

Competitive Comparison of Faes Farma's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Faes Farma's Shiller PE Ratio falls into.



Faes Farma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Faes Farma's E10 for the quarter that ended in Jun. 2023 is calculated as:

For example, Faes Farma's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0/120.2784*120.2784
=0.000

Current CPI (Jun. 2023) = 120.2784.

Faes Farma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201309 0.059 100.597 0.071
201312 -0.010 101.306 -0.012
201403 0.036 100.139 0.043
201406 0.046 101.081 0.055
201409 0.046 100.441 0.055
201412 0.009 100.251 0.011
201503 0.031 99.474 0.037
201506 0.038 101.138 0.045
201509 0.045 99.559 0.054
201512 0.020 100.268 0.024
201603 0.037 98.638 0.045
201606 0.042 100.333 0.050
201609 0.056 99.737 0.068
201612 0.026 101.842 0.031
201703 0.000 100.896 0.000
201706 0.062 101.848 0.073
201709 0.060 101.524 0.071
201712 0.000 102.975 0.000
201803 0.000 102.122 0.000
201806 0.000 104.165 0.000
201809 0.000 103.818 0.000
201812 0.000 104.193 0.000
201903 0.000 103.488 0.000
201906 0.000 104.612 0.000
201909 0.000 103.905 0.000
201912 0.000 105.015 0.000
202003 0.000 103.469 0.000
202006 0.000 104.254 0.000
202009 0.000 103.521 0.000
202012 0.000 104.456 0.000
202103 0.000 104.857 0.000
202106 0.000 107.102 0.000
202109 0.000 107.669 0.000
202112 0.000 111.298 0.000
202203 0.000 115.153 0.000
202206 0.000 118.044 0.000
202209 0.000 117.221 0.000
202212 0.000 117.650 0.000
202303 0.000 118.948 0.000
202306 0.000 120.278 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Faes Farma  (OTCPK:FSXMF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Faes Farma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Faes Farma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Faes Farma (Faes Farma) Business Description

Traded in Other Exchanges
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (Faes Farma) Headlines

No Headlines